<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The authors examined the effects of both intermittent reperfusion and nitric <z:chebi fb="177" ids="25741,29356">oxide</z:chebi> synthase (NOS) inhibition, caused by NG-<z:chebi fb="13" ids="29785">nitro</z:chebi>-<z:chebi fb="0" ids="16467,29952">L-arginine</z:chebi> <z:chebi fb="36" ids="29309">methyl</z:chebi> <z:chebi fb="21" ids="35701">ester</z:chebi> (L-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">NAME</z:e>) during episodes of focal <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> induced to simulate the neurosurgical setting </plain></SENT>
<SENT sid="1" pm="."><plain>Seventy-eight Wistar rats underwent single (60 minutes of <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>) or repetitive (four 15-minute periods of <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> separated by 5 minutes of reperfusion) episodes of middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> while under anesthesia (1.0% <z:chebi fb="2" ids="5615">halothane</z:chebi>) </plain></SENT>
<SENT sid="2" pm="."><plain>Twenty-four hours after the procedure, the animals were given neurological examinations and then sacrificed for histological preparation and examination </plain></SENT>
<SENT sid="3" pm="."><plain>The intermittent reperfusion groups tended to have smaller mean cortical infarctions </plain></SENT>
<SENT sid="4" pm="."><plain>There was also a trend showing a decrease in infarction size in groups given L-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">NAME</z:e> </plain></SENT>
<SENT sid="5" pm="."><plain>The combination of intermittent reperfusion and preischemic administration of L-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">NAME</z:e> (10 mg/kg) resulted in a 65% reduction in infarction size (p &lt; 0.05) when compared to that caused by 60 minutes of single occlusion without L-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">NAME</z:e> </plain></SENT>
<SENT sid="6" pm="."><plain>The use of NOS inhibition combined with intermittent reperfusion may be a technique to provide intraoperative cerebral protection during neurovascular procedures that require temporary <z:e sem="disease" ids="C1096458" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">vascular occlusion</z:e> </plain></SENT>
</text></document>